A variable quality characteristic is assumed to follow the new Weibull-Pareto distribution. Based on the evaluated percentiles of sample statistics like mean, median, midrange, range and standard deviation, the control limits for the respective control charts are developed. The admissibility and power of the control limits are assessed in comparison with those based on the popular Shewhart control limits.
The design of acceptance sampling plans is developed under truncated life testing based on the percentiles of half normal distribution. The minimum sample size necessary to ensure the specified life percentile is obtained under a given consumer's risk. The operating characteristic values of the sampling plans as well as the producer's risk are presented. The results are illustrated by examples.
In this article , acceptance sampling plans are developed for the Linear Failure Rate Distribution percentiles when the life test is truncated at a pre-specified time. The minimum sample size necessary to ensure the specified life percentile is obtained under a given consumerś risk. The operating characteristic values of the sampling plans as well as the producerś risk are presented.
A probability model of a quality characteristic is assumed to follow a log logistic distribution. This article proposes variable control charts, termed extreme value charts, based on the extreme values of each subgroup. The control chart constants depend on the probability model of the extreme order statistics and the size of each subgroup. The analysis of means (ANOM) technique for a skewed population is applied with respect to log logistic distribution. Results are illustrated using examples based on real data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.